PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.560.02 (-0.36%)
5.56 - 5.56
4.95 - 8.28
45 / 2.4K (Avg.)
-278.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-9.62%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
6.88%
Positive gross profit growth while STERV.HE is negative. John Neff would see a clear operational edge over the competitor.
12.52%
Positive EBIT growth while STERV.HE is negative. John Neff might see a substantial edge in operational management.
12.52%
Positive operating income growth while STERV.HE is negative. John Neff might view this as a competitive edge in operations.
-9.83%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-9.52%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-9.52%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.08%
Share change of 0.08% while STERV.HE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.08%
Diluted share count expanding well above STERV.HE's 0.04%. Michael Burry would fear significant dilution to existing owners' stakes.
-100.00%
Dividend reduction while STERV.HE stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
80.06%
Positive OCF growth while STERV.HE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
798.98%
Positive FCF growth while STERV.HE is negative. John Neff would see a strong competitive edge in net cash generation.
14.23%
10Y revenue/share CAGR above 1.5x STERV.HE's 2.02%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
11.52%
5Y revenue/share CAGR above 1.5x STERV.HE's 5.50%. David Dodd would look for consistent product or market expansions fueling outperformance.
19.20%
3Y revenue/share CAGR at 75-90% of STERV.HE's 23.29%. Bill Ackman would expect new product strategies to close the gap.
222.39%
10Y OCF/share CAGR under 50% of STERV.HE's 4849.88%. Michael Burry would worry about a persistent underperformance in cash creation.
323.88%
5Y OCF/share CAGR above 1.5x STERV.HE's 50.79%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
64.02%
3Y OCF/share CAGR under 50% of STERV.HE's 167.60%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
856.85%
Net income/share CAGR at 50-75% of STERV.HE's 1211.74%. Martin Whitman might question if the firm’s product or cost base lags behind.
27.58%
Positive 5Y CAGR while STERV.HE is negative. John Neff might view this as a strong mid-term relative advantage.
218.95%
3Y net income/share CAGR above 1.5x STERV.HE's 24.34%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
162.49%
10Y equity/share CAGR above 1.5x STERV.HE's 102.47%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
72.58%
5Y equity/share CAGR at 75-90% of STERV.HE's 90.28%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
53.08%
3Y equity/share CAGR at 75-90% of STERV.HE's 66.55%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
-100.00%
Cut dividends over 10 years while STERV.HE stands at 5599.86%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.30%
Firm’s AR is declining while STERV.HE shows 0.19%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
7.14%
Inventory growth well above STERV.HE's 8.93%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
0.87%
Positive asset growth while STERV.HE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-6.05%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-0.29%
We’re deleveraging while STERV.HE stands at 10.20%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-7.92%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.